NCT00608153View on ClinicalTrials.gov

Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide

CompletedOBSERVATIONAL
Enrollment

1,773

Participants

Timeline

Start Date

January 31, 2007

Study Completion Date

September 30, 2007

Conditions
Essential Hypertension
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY